Showing results (551-560 of 651) with videos related to
Sort By:
Pageof 66
Neuropsychopharmacology Reports|June 23, 2022
Effect of CNTNAP2 polymorphism on receptive language in children with autism spectrum disorder without language developmental delayYuka Shiota, Tetsu Hirosawa, Yuko Yoshimura, et al.Neuropsychopharmacology Reports|June 24, 2022
A case of mood disorder with severe side effects of antidepressants in association with resistance to thyroid hormone beta with a THRB mutationHazuki Komahashi-Sasaki, Norio Yasui-Furukori, Ryo Maehara, et al.Neuropsychopharmacology Reports|June 24, 2022
Residual effects of low dose of suvorexant, zolpidem, and ramelteon in healthy elderly subjects: A randomized double-blind studySachiko Ito Uemura, Aya Imanishi, Yoshino Terui, et al.Neuropsychopharmacology Reports|June 18, 2022
Prolonged extrapyramidal symptoms induced by long-term, intermittent administration of low-dose olanzapine along with metoclopramide for emesis: A case reportShoko Sakamoto, Yasuhiko Deguchi, Sawako Uchida, et al.Neuropsychopharmacology Reports|July 1, 2022
Development and acceptability of a decision aid for major depressive disorder considering discontinuation of antidepressant treatment after remissionYumi Aoki, Yoshikazu Takaesu, Hajime Baba, et al.Neuropsychopharmacology Reports|May 27, 2021
Inter-breeder differences in prepulse inhibition deficits of C57BL/6J mice in a maternal immune activation modelYutaro Kobayashi, Hiroyoshi Inaba, Yuriko Iwakura, et al.Neuropsychopharmacology Reports|February 6, 2020
Plasma levels of matrix metalloproteinase-9 (MMP-9) are associated with cognitive performance in patients with schizophreniaNoriko Kudo, Hidenaga Yamamori, Tamaki Ishima, et al.Neuropsychopharmacology Reports|November 22, 2022
Plasma neuropeptide levels in patients with schizophrenia, bipolar disorder, or major depressive disorder and healthy controls: A multiplex immunoassay studyShinsuke Hidese, Fuyuko Yoshida, Ikki Ishida, et al.Neuropsychopharmacology Reports|May 5, 2023
A case of panic attack developing after THC-O acetate inhalation using an e-cigarette deviceNorio Sugawara, Norio Yasui-Furukori, Kazutaka ShimodaNeuropsychopharmacology Reports|March 27, 2021
Neuropsin-dependent and -independent behavioral taggingYuka Suzuki, Yuya Yoda, Yasuyuki IshikawaPageof 66